Nureca IPO share allocation finalised: How to check application status1 min read . Updated: 24 Feb 2021, 08:55 AM IST
- The retail investor portion in Nureca IPO was subscribed nearly 170 times
The share allocation of Nureca Limited has been finalised. Link Intime India Private Ltd is the registrar of the issue and will be managing share allocation and refund. Investors can check the status of their application status on the website of the registrar or BSE. Shares of Nureca Limited, which is into the business home healthcare and wellness products, are likely to get listed on February 26, 2021.
The ₹100 crore public issue of Nureca, which had opened on February 15 and closed on February 17, was subscribed nearly 40 times. It had received bids for 5,59,65,945 shares against 14,01,595 shares on offer.
The category meant for qualified institutional buyers (QIBs) was subscribed 3.10 times, non-institutional investors 31.59 times and retail individual investors (RIIs) 166.65 times. The price range for the offer was at ₹396-400 per share while ITI Capital was the manager to the offer.
Last week, Nureca raised ₹44.55 crore from two anchor investors - Nexpact Limited and Next Orbit Ventures Limited - at an upper price band of ₹400 per equity share.
Nureca is a B2C company engaged in the marketing of home healthcare & wellness products. The company sells products through a brand portfolios consisting of Dr Trust, Trumom and Dr Physio.
Nureca is a digital-first company, wherein it sells its products through online channel partners such as e-commerce players, distributors and retailers. Currently, 95% of the revenue is derived through digital channels. Further, the company also sells its products through their own website drtrust.in
Nureca's had reported revenues of ₹99.4 crore FY20 with profit of ₹6.4 crore.
Its products are classified into five categories such as chronic device products which include products such as blood pressure monitors, pulse oximeters, thermometers, nebulizers, self monitoring glucose devices, humidifier and steamers; orthopaedic products which include rehabilitation products such as wheelchairs, walkers, lumbar and tailbone supports and physiotherapy electric massagers; mother and child products which include products such as breast pumps, bottle sterilizers, bottle warmers, car seats and baby carry cots; nutrition supplements which include products such as fish oil, multivitamins, probiotics, botin, apple cider and vinegar; and lifestyle products which include products such as smart scales, aroma diffusers and fitness tracker.
The share allocation in RailTel IPO, which closed last week, is likely to be finalised today, according to brokerages, while listing may happen on February 26.